Aurinia Pharmaceuticals Stock Performance
as on September 3, 2026 at 6:59 am IST
Day's Low
Day's High
$15.93$16.46
2.27%
Downside
0.98%
Upside
52 Week's Low
52 Week's High
$10.34$19.2536.56%
Downside
18.10%
Upside
Aurinia Pharmaceuticals share price movements today
- Previous Close
- $16.05
- Open
- $16.17
- Volume
- 649.9K
- Market Cap
- $2.1B
- Day's Low - High
- $15.93 - $16.46
- 52 Week Low - High
- $10.34 - $19.25
Aurinia Pharmaceuticals Historical Returns
- 1 Month Return
- + 7.86 %
- 3 Month Return
- + 4.29 %
- 1 Year Return
- + 37.41 %
- 3 Year Return
- + 69.66 %
- 5 Year Return
- -8.55 %
Aurinia Pharmaceuticals Stock Fundamentals & Key Indicators
Check Aurinia Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
0.944
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.76%
PE Ratio (TTM)
7.07
Industry PE ratio
-13.558214285714286
PEG Ratio
0EBITDA
179.8M
Revenue (TTM)
311.5M
Profit Margin
100.84%
Return On Equity TTM
66.12%
Aurinia Pharmaceuticals Stock Valuation
Track how Aurinia Pharmaceuticals P/E has moved over time to understand its valuation trends.
Aurinia Pharmaceuticals in the last 5 years
Lowest (-41.34x)
September 30, 2024
Industry (-13.56x)
September 2, 2026
Today (7.07x)
September 2, 2026
Highest (163.18x)
December 31, 2024
Today’s Price to Earnings Ratio: 7.07x
Aurinia Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurinia Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $2.1B | -8.55% | 7.07 | 100.84% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $137.9B | 174.9% | 31.92 | 86.04% | NA | |
| BUY | $61.6B | -61.21% | -7.98 | -12.57% | NA | |
| BUY | $82.3B | 21.91% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for Aurinia Pharmaceuticals Stock including INR - Dollar returns
The Aurinia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Aurinia Pharmaceuticals investment value today
Current value as on today
₹1,50,596
Returns
₹50,596
(+50.6%)
Returns from Aurinia Pharmaceuticals Stock
₹39,555 (+39.55%)
Dollar Impact
₹11,041 (+11.04%)
Analyst Recommendation on Aurinia Pharmaceuticals Stock
Based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Aurinia Pharmaceuticals. Average target price of $17.86
Aurinia Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Aurinia Pharmaceuticals.
What analysts predicted
8.73%UPSIDE
Target Price
$17.86
Current Price
$16.3
Analyzed by
3 Analysts
Target
$17.86
Aurinia Pharmaceuticals target price $17.86, a slight upside of 8.73% compared to current price of $16.3. According to 3 analysts rating.
Indian Investors' Interest in Aurinia Pharmaceuticals Stock
Search interest for Aurinia Pharmaceuticals Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1% versus previous 30 day period
Aurinia Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals News & Key Events
Today's Timeline - 15 October
Wed, 04:13 PM
-Aurinia Pharmaceuticals to present new LUPKYNIS data at ACR and ASN conferences, enhancing understanding of lupus nephritis treatment.
Insights on Aurinia Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 34.35M → 37.41M (in $), with an average increase of 8.2% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 59.86M → 83.22M (in $), with an average increase of 5.3% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, AUPH has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 1 month, AUPH stock has moved up by 7.9%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 500.3%
About Aurinia Pharmaceuticals
| Organisation | Aurinia Pharmaceuticals |
| Headquarters | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
| Industry | Biotechnology |
| CEO | Mr. Kevin C. Tang |
| E-voting on shares | Click here to vote |
Key Management of Aurinia Pharmaceuticals
Name | Title |
|---|---|
Mr. Stewart M. Kroll | Chief Development Officer |
Mr. Kevin C. Tang | Chairman & CEO |
Mr. Stephen P. Robertson | Chief Legal Officer, Corporate Secretary & Chief Compliance Officer |
Mr. Peter S. Greenleaf M.B.A. | Consultant |
Mr. Michael S. Hearne CPA | Chief Financial Officer |
Mr. Ryan Cole | Chief Operating Officer |
Mr. Thomas Wei | Chief Scientific Officer |
FAQs
What is Aurinia Pharmaceuticals share price today?
Aurinia Pharmaceuticals share price today is $16.30 as on at the close of the market. Aurinia Pharmaceuticals share today touched a day high of $16.46 and a low of $15.93.
What is the 52 week high and 52 week low for Aurinia Pharmaceuticals share?
Aurinia Pharmaceuticals share touched a 52 week high of $19.25 on and a 52 week low of $10.34 on . Aurinia Pharmaceuticals stock price today i.e. is closed at $16.30,which is 15.32% down from its 52 week high and 57.64% up from its 52 week low.
What is Aurinia Pharmaceuticals's market capitalisation today?
Aurinia Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Aurinia Pharmaceuticals Stock (AUPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aurinia Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aurinia Pharmaceuticals Shares that will get you 0.0920 shares as per Aurinia Pharmaceuticals share price of $16.30 per share as on September 3, 2026 at 1:29 am IST.
What is the minimum amount required to buy Aurinia Pharmaceuticals Stock (AUPH) from India?
Indian investors can start investing in Aurinia Pharmaceuticals (AUPH) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Aurinia Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aurinia Pharmaceuticals share’s latest price of $16.30 as on September 3, 2026 at 1:29 am IST, you will get 0.6135 shares of Aurinia Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Aurinia Pharmaceuticals has given to Indian investors in the last 5 years?
Aurinia Pharmaceuticals stock has given -8.55% share price returns and 30.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?